CONCLUSIONS: Such barriers to access and desired design features should be strongly considered in the development of neurostimulation therapies for pediatric patients with ADHD. Pediatric and adolescent patients with ADHD require attentive device design considerations to achieve therapeutic adherence in a real-world setting.
